NASDAQ · UBXG

U – BX Technology Ltd.

$5.03 -$0.01 (-0.20%) 1D

Key Metrics

$9.14M
Market cap
P/E · TTM
$29.67M
Revenue · TTM
−$2.72M
Net income
EPS · TTM $-0.10
Dividend yield
Free cash flow
Beta · 1Y 0.14
EBITDA · TTM
Gross margin 0.8%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 12
    The stock moved +64.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 12
  • May 20
    From its Mar 31 high, the share price fell 97%.

    Peak close $83.50 on Mar 31; trough close $2.87 on May 20. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -97%
  • Mar 31
    The stock moved +112.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 31

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$9.14M
Enterprise value
Shares outstanding1.8M
52-wk range$1.62 – $83.50
Avg volume · 20D214.2K
Net cash
Book value / share$1.30
ExchangeNASDAQ
About U – BX Technology Ltd.
IPO dateMar 28, 2024
Employees15

U-BX Technology Ltd focuses on providing value-added services using artificial intelligence-driven technology to businesses in the insurance industry, including insurance carriers and brokers.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.31
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 0.8%
Operating -10.5%
Net -9.2%
FCF
ROE / ROIC -10.7% · —

Financial Health

Current ratio20.55
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$17.00M

Cash Flow · TTM

Operating CF −$1.87M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

4.5
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings